UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000045991
Receipt number R000052500
Scientific Title Observational study for the usefulness and safety of endoscopic transpapillary gallbladder drainage for acute cholecystitis
Date of disclosure of the study information 2021/11/05
Last modified on 2023/11/15 17:58:08

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Observational study for the usefulness and safety of endoscopic transpapillary gallbladder drainage (ETGBD) for acute cholecystitis

Acronym

Observational study for the usefulness and safety of ETGBD for acute cholecystitis

Scientific Title

Observational study for the usefulness and safety of endoscopic transpapillary gallbladder drainage for acute cholecystitis

Scientific Title:Acronym

Observational study for the usefulness and safety of ETGBD for acute cholecystitis

Region

Japan


Condition

Condition

acute cholecystitis

Classification by specialty

Gastroenterology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To assess efficacy and safety between group of one and two gallbladder stent during ETGBD

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

1. Presence or absence of difficulty in intubation into the gallbladder
2. Long-term patency rate
3. Presence or absence of complications

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Cases in which ETGBD was performed for acute cholecystitis for which surgery was judged to be unsuitable between April 1, 2015 and March 31, 2027.

Key exclusion criteria

none

Target sample size

80


Research contact person

Name of lead principal investigator

1st name Kosuke
Middle name
Last name Takahashi

Organization

Nagasaki University

Division name

Department of Gastroenterology and Hepatology

Zip code

852-8501

Address

1-7-1, Sakamoto, Nagasaki 852-8501, JAPAN

TEL

095-819-7481

Email

takapochi0809@gmail.com


Public contact

Name of contact person

1st name Kosuke
Middle name
Last name Takahashi

Organization

Nagasaki University

Division name

Department of Gastroenterology and Hepatology

Zip code

852-8501

Address

1-7-1, Sakamoto, Nagasaki 852-8501, JAPAN

TEL

095-819-7481

Homepage URL


Email

takapochi0809@gmail.com


Sponsor or person

Institute

Nagasaki University

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nagasaki University Hospital Clinical Research Ethics Committee

Address

1-7-1 Sakamoto, Nagasaki-shi, Nagasaki-ken,Japan

Tel

095-819-7229

Email

gaibushikin@ml.nagasaki-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 11 Month 05 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2021 Year 11 Month 02 Day

Date of IRB

2021 Year 12 Month 27 Day

Anticipated trial start date

2021 Year 12 Month 01 Day

Last follow-up date

2028 Year 09 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

none


Management information

Registered date

2021 Year 11 Month 05 Day

Last modified on

2023 Year 11 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000052500